While we gather around the table on Thursday, many of us will give thanks for the blessings in our lives. Will workers’ comp be among them? In this edition of Inside Workers’ Comp, we asked industry experts Chikita Mann, Mark
While we gather around the table on Thursday, many of us will give thanks for the blessings in our lives. Will workers’ comp be among them? In this edition of Inside Workers’ Comp, we asked industry experts Chikita Mann, Mark
This session will help attendees build a foundation for positive and consistent ethical decision making and how to assess self-performance.
In a recent article, Jim Begg, Vice President of National Accounts for Apricus, highlights the critical role of effective discharge planning in helping patients recover swiftly and safely.
Streamline your claims process and support your team with our cutting-edge solutions.
In a move to address its high rates of vehicle accident settlements, the state of Georgia has passed new legislation aimed at clarifying and streamlining the settlement process.
This collection of case studies demonstrates how Apricus Specialty Solutions has successfully navigated the complexities of transitioning injured employees from hospital to home. Each case highlights unique challenges and innovative solutions that were implemented to provide continuous care, promote patient independence, and improve overall quality of life. Through close collaboration with medical providers, case managers, and local agencies, Apricus Specialty Solutions delivers tailored care plans that address the specific needs of each injured employee, resulting in brighter outcomes.
Despite decreases in utilization and cost per claim, opioids remain the No. 1 drug class in Enlyte’s 2024 Drug Trends Report. However, due to concerns with safety and overutilization, increased focus on usage guidelines as well as alternatives to pain management are gaining momentum — including those whose active ingredients drive from things you might not imagine, like pufferfish, cacti and chili peppers. Enlyte’s Nikki Wilson explores this and more in our Part 3 drug trends analysis.